The initial success of the copyright undeniably revolutionized the medication landscape, but placing funds in companies strongly reliant on generic versions presents a uncertain picture. Despite early profits were significant, the expiration of patents and the emergence of cheaper alternatives have eroded the customer base. Thus, a thorough analysi